BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 29773426)

  • 1. Stem cell transcription factor SOX2 in synovial sarcoma and other soft tissue tumors.
    Zayed H; Petersen I
    Pathol Res Pract; 2018 Jul; 214(7):1000-1007. PubMed ID: 29773426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma.
    Amary MF; Berisha F; Bernardi Fdel C; Herbert A; James M; Reis-Filho JS; Fisher C; Nicholson AG; Tirabosco R; Diss TC; Flanagan AM
    Mod Pathol; 2007 Apr; 20(4):482-96. PubMed ID: 17334349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Roles of immunohistochemistry and detection of SYT-SSX fusion gene in diagnosis of synovial sarcoma].
    Sun Y; Sun BC; Zhao XL; Wang J; Chen J; Li XQ; Feng YM; Fang ZW; Hao XS
    Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):480-4. PubMed ID: 17845763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier.
    Tamaki S; Fukuta M; Sekiguchi K; Jin Y; Nagata S; Hayakawa K; Hineno S; Okamoto T; Watanabe M; Woltjen K; Ikeya M; Kato T; Toguchida J
    PLoS One; 2015; 10(11):e0142991. PubMed ID: 26571495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of circulating tumor cells and cell-free nucleic acids is an infrequent event in synovial sarcoma: liquid biopsy analysis of 15 patients diagnosed with synovial sarcoma.
    Mihály D; Nagy N; Papp G; Pápai Z; Sápi Z
    Diagn Pathol; 2018 Oct; 13(1):81. PubMed ID: 30326929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic utility of dual-color break-apart chromogenic in situ hybridization for the detection of rearranged SS18 in formalin-fixed, paraffin-embedded synovial sarcoma.
    Motoi T; Kumagai A; Tsuji K; Imamura T; Fukusato T
    Hum Pathol; 2010 Oct; 41(10):1397-404. PubMed ID: 20594581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Immunohistochemistry With Antibodies to SS18-SSX Chimeric Proteins and C-Terminus of SSX Protein for Synovial Sarcoma Differential Diagnosis.
    Lasota J; Chłopek M; Kaczorowski M; Natálie K; Ryś J; Kopczyński J; Sulaieva O; Michal M; Kruczak A; Harazin-Lechowska A; Szczepaniak M; Koshyk O; Hałoń A; Czapiewski P; Abdullaev Z; Kowalik A; Aldape KD; Michal M; Miettinen M
    Am J Surg Pathol; 2024 Jan; 48(1):97-105. PubMed ID: 37899499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When used together SS18-SSX fusion-specific and SSX C-terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in most cases.
    Zaborowski M; Vargas AC; Pulvers J; Clarkson A; de Guzman D; Sioson L; Maclean F; Chou A; Gill AJ
    Histopathology; 2020 Oct; 77(4):588-600. PubMed ID: 32559341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of chromosomal aberration in paraffin-embedded synovial sarcoma tissues by fluorescence in-situ hybridization].
    Cheng YF; Wang J; Zhou XY; Zhou XK; Lu YM; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):577-81. PubMed ID: 18070443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reappraisal of TLE-1 immunohistochemical staining and molecular detection of SS18-SSX fusion transcripts for synovial sarcoma.
    Chuang HC; Hsu SC; Huang CG; Hsueh S; Ng KF; Chen TC
    Pathol Int; 2013 Dec; 63(12):573-80. PubMed ID: 24422953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent TRPS1 expression in synovial sarcoma is associated with SS18-SSX fusion oncoprotein activity.
    Cloutier JM; Ingram DR; Wani K; Lazar AJ; Wang WL
    Hum Pathol; 2022 Dec; 130():88-94. PubMed ID: 36162599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel FISH assay for SS18-SSX fusion type in synovial sarcoma.
    Surace C; Panagopoulos I; Pålsson E; Rocchi M; Mandahl N; Mertens F
    Lab Invest; 2004 Sep; 84(9):1185-92. PubMed ID: 15208645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma.
    Kadoch C; Crabtree GR
    Cell; 2013 Mar; 153(1):71-85. PubMed ID: 23540691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
    Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
    Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.
    Trautmann M; Sievers E; Aretz S; Kindler D; Michels S; Friedrichs N; Renner M; Kirfel J; Steiner S; Huss S; Koch A; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Waha A; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
    Oncogene; 2014 Oct; 33(42):5006-16. PubMed ID: 24166495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlating SS18-SSX immunohistochemistry (IHC) with SS18 fluorescent in situ hybridization (FISH) in synovial sarcomas: a study of 36 cases.
    Tay TKY; Sukma NB; Lim TH; Kuick CH; Goh JY; Chang KTE
    Virchows Arch; 2021 Oct; 479(4):785-793. PubMed ID: 34091760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SS18-SSX-Dependent YAP/TAZ Signaling in Synovial Sarcoma.
    Isfort I; Cyra M; Elges S; Kailayangiri S; Altvater B; Rossig C; Steinestel K; Grünewald I; Huss S; Eßeling E; Mikesch JH; Hafner S; Simmet T; Wozniak A; Schöffski P; Larsson O; Wardelmann E; Trautmann M; Hartmann W
    Clin Cancer Res; 2019 Jun; 25(12):3718-3731. PubMed ID: 30814111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
    Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
    Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
    Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary synovial sarcoma of lung: a clinicopathological analysis of 12 cases].
    Zhang XW; Wei JG; Sun JP; Xu ZG; Cheng Q; Zhang L; Kong LF
    Zhonghua Bing Li Xue Za Zhi; 2023 Nov; 52(11):1120-1125. PubMed ID: 37899317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.